Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    April 2017

  1. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
    N Engl J Med. 2017;376:1507-1516.
    PubMed     Text format     Abstract available


  2. ROSENBERG JB, Tsui I
    Screening for Diabetic Retinopathy.
    N Engl J Med. 2017;376:1587-1588.
    PubMed     Text format    


  3. MAYER-DAVIS EJ, Lawrence JM, Dabelea D, Divers J, et al
    Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
    N Engl J Med. 2017;376:1419-1429.
    PubMed     Text format     Abstract available


  4. RAWSHANI A, Rawshani A, Franzen S, Eliasson B, et al
    Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
    N Engl J Med. 2017;376:1407-1418.
    PubMed     Text format     Abstract available


  5. INGELFINGER JR, Jarcho JA
    Increase in the Incidence of Diabetes and Its Implications.
    N Engl J Med. 2017;376:1473-1474.
    PubMed     Text format    


  6. LAVERY K, Gilden DJ, Saint S, Judson MA, et al
    A Bare-Bones Approach.
    N Engl J Med. 2017;376:1371-1376.
    PubMed     Text format    


    March 2017
  7. IPP E, Genter P, Childress K
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890-1.
    PubMed     Text format    



  8. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;379:890-1.
    PubMed     Text format    


  9. COSMI F, Laini R, Nicolucci A
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:890.
    PubMed     Text format    


  10. WILLIAMS TC, Stewart E
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891.
    PubMed     Text format    



  11. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2017;376:891-2.
    PubMed     Text format    


    February 2017
  12. LUDVIGSSON J, Wahlberg J, Casas R
    Intralymphatic Injection of Autoantigen in Type 1 Diabetes.
    N Engl J Med. 2017;376:697-699.
    PubMed     Text format    


  13. SCHAUER PR, Bhatt DL, Kirwan JP, Wolski K, et al
    Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.
    N Engl J Med. 2017;376:641-651.
    PubMed     Text format     Abstract available


    December 2016
  14. MORAN-THOMAS A
    Breakthroughs for Whom? Global Diabetes Care and Equitable Design.
    N Engl J Med. 2016;375:2317-2319.
    PubMed     Text format    


  15. FERENCE BA, Robinson JG, Brook RD, Catapano AL, et al
    Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.
    N Engl J Med. 2016;375:2144-2153.
    PubMed     Text format     Abstract available


    November 2016
  16. ANDERS HJ, Davis JM, Thurau K
    Nephron Protection in Diabetic Kidney Disease.
    N Engl J Med. 2016;375:2096-2098.
    PubMed     Text format    


  17. ALEGRE-DIAZ J, Herrington W, Lopez-Cervantes M, Gnatiuc L, et al
    Diabetes and Cause-Specific Mortality in Mexico City.
    N Engl J Med. 2016;375:1961-1971.
    PubMed     Text format     Abstract available


  18. GORDON CE, Vantzelfde S, Francis JM
    Acetazolamide in Lithium-Induced Nephrogenic Diabetes Insipidus.
    N Engl J Med. 2016;375:2008-2009.
    PubMed     Text format    


  19. PAREEK A, Chandurkar N, Naidu K
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1800.
    PubMed     Text format    


  20. WAKISAKA M
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1799-1800.
    PubMed     Text format    



  21. Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1799-1802.
    PubMed     Text format    


  22. CORREIA LC, Latado A, Porzsolt F
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1798.
    PubMed     Text format    


  23. COHEN S, Beckey C
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797.
    PubMed     Text format    



  24. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-1799.
    PubMed     Text format    


  25. PARVING H-H, Lambers-Heerspink H, de Zeeuw D
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016;375:1800-1.
    PubMed     Text format    


  26. ALVAREZ-VILLALOBOS NA, Trevino-Alvarez AM, Gonzalez-Gonzalez JG
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016;375:1797-8.
    PubMed     Text format    


    October 2016
  27. HIROSE Y, Kaida H
    Emphysematous Pyelonephritis.
    N Engl J Med. 2016;375:1671.
    PubMed     Text format    


  28. MACDONALD SM, Rapalino O, Sherry NA, Cohen AB, et al
    Case 32-2016. A 20-Year-Old Man with Gynecomastia.
    N Engl J Med. 2016;375:1567-1579.
    PubMed     Text format    


  29. BYRNE TN, Stone JH, Pillai SS, Rapalino O, et al
    Case Records of the Massachusetts General Hospital. Case 31-2016. A 53-Year-Old Man with Diplopia, Polydipsia, and Polyuria.
    N Engl J Med. 2016;375:1469-1480.
    PubMed     Text format    



  30. Diabetic Sensory and Motor Neuropathy.
    N Engl J Med. 2016;375:1402.
    PubMed     Text format    


    September 2016
  31. MARSO SP, Bain SC, Consoli A, Eliaschewitz FG, et al
    Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  32. PERSAUD SJ, Jones PM
    A Wake-up Call for Type 2 Diabetes?
    N Engl J Med. 2016;375:1090-2.
    PubMed     Text format    


  33. RAN M, Wang Y
    Generalized Granuloma Annulare Associated with Diabetes Mellitus.
    N Engl J Med. 2016;375:e21.
    PubMed     Text format    


  34. ZHANG L, Long J, Jiang W, Shi Y, et al
    Trends in Chronic Kidney Disease in China.
    N Engl J Med. 2016;375:905-6.
    PubMed     Text format    


  35. WANG HS, Shih MC
    Emphysematous Prostatitis.
    N Engl J Med. 2016;375:879.
    PubMed     Text format    


    August 2016
  36. STEWART ZA, Wilinska ME, Hartnell S, Temple RC, et al
    Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
    N Engl J Med. 2016;375:644-54.
    PubMed     Text format     Abstract available


    July 2016

  37. Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
    N Engl J Med. 2016;375:398.
    PubMed     Text format     Abstract available


    June 2016
  38. MUSTAFA OM, Aduriz-Lorenzo PM
    IMAGES IN CLINICAL MEDICINE. Hypopyon and Klebsiella Sepsis.
    N Engl J Med. 2016;374:e33.
    PubMed     Text format    


  39. SAHIN M, Corapcioglu D
    Metformin versus Placebo in Obese Pregnant Women without Diabetes.
    N Engl J Med. 2016;374:2501-2.
    PubMed     Text format     Abstract available


  40. STANFORD FC, Alfaris N, Misra M
    Metformin versus Placebo in Obese Pregnant Women without Diabetes.
    N Engl J Med. 2016;374:2501-2.
    PubMed     Text format     Abstract available



  41. Metformin versus Placebo in Obese Pregnant Women without Diabetes.
    N Engl J Med. 2016;374:2501-2.
    PubMed     Text format     Abstract available


  42. WANNER C, Inzucchi SE, Lachin JM, Fitchett D, et al
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  43. INGELFINGER JR, Rosen CJ
    Cardiac and Renovascular Complications in Type 2 Diabetes - Is There Hope?
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  44. MARSO SP, Daniels GH, Brown-Frandsen K, Kristensen P, et al
    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  45. BAYRY J
    Repressing Immunity in Autoimmune Disease.
    N Engl J Med. 2016;374:2090-2.
    PubMed     Text format    


  46. KHONSARI RH, Ruhin B
    IMAGES IN CLINICAL MEDICINE. Loose Teeth and Excessive Thirst.
    N Engl J Med. 2016;374:e25.
    PubMed     Text format    


  47. ALEXANDER JH, Smith PK
    Coronary-Artery Bypass Grafting.
    N Engl J Med. 2016;374:1954-64.
    PubMed     Text format    


    April 2016
  48. SWEDBERG K, Borer JS, Pitt B, Pocock S, et al
    Challenges to Data Monitoring Committees When Regulatory Authorities Intervene.
    N Engl J Med. 2016;374:1580-4.
    PubMed     Text format    


  49. TOUGAS G, Aftring RP
    Novartis Reply to the ATMOSPHERE Data Monitoring Committee.
    N Engl J Med. 2016;374:1586-7.
    PubMed     Text format    


  50. SALMONSON T, Janssen H, Sudhop T, Stahl E, et al
    Regulatory Reply to the ATMOSPHERE Data Monitoring Committee.
    N Engl J Med. 2016;374:1585-6.
    PubMed     Text format    


  51. VINIK AI
    CLINICAL PRACTICE. Diabetic Sensory and Motor Neuropathy.
    N Engl J Med. 2016;374:1455-64.
    PubMed     Text format    



  52. Diabetic Sensory and Motor Neuropathy.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  53. MCMURRAY JJ, Krum H, Abraham WT, Dickstein K, et al
    Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


    March 2016
  54. FILION KB, Azoulay L, Platt RW, Dahl M, et al
    A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.
    N Engl J Med. 2016;374:1145-54.
    PubMed     Text format     Abstract available


  55. DEROSA G, Maffioli P
    Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2016;374:1095.
    PubMed     Text format    


  56. TSUTSUMI Y, Tsujimoto Y, Ikenoue T
    Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2016;374:1094-5.
    PubMed     Text format    


  57. PFEFFER MA, Claggett B, Probstfield JL
    Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2016;374:1095-6.
    PubMed     Text format    


  58. ROSENSTEIN R, Hough A
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1093-4.
    PubMed     Text format    


  59. EDWARDS JL
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1093.
    PubMed     Text format    


  60. FISCHEREDER M, Schonermarck U
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1092-3.
    PubMed     Text format    


  61. SARAFIDIS PA, Tsapas A
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1092.
    PubMed     Text format    


  62. ZINMAN B, Lachin JM, Inzucchi SE
    Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
    N Engl J Med. 2016;374:1094.
    PubMed     Text format    


    February 2016
  63. ZHANG Y, Niu J, Choi HK
    Excess Mortality among Persons with Type 2 Diabetes.
    N Engl J Med. 2016;374:788.
    PubMed     Text format    


  64. BYERS T
    Excess Mortality among Persons with Type 2 Diabetes.
    N Engl J Med. 2016;374:788.
    PubMed     Text format    


  65. LIND M, Wedel H, Rosengren A
    Excess Mortality among Persons with Type 2 Diabetes.
    N Engl J Med. 2016;374:788-9.
    PubMed     Text format    


  66. SYNGELAKI A, Nicolaides KH, Balani J, Hyer S, et al
    Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
    N Engl J Med. 2016;374:434-43.
    PubMed     Text format     Abstract available


    December 2015
  67. WALTER JE, Armanios M, Shah U, Friedmann AM, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 41-2015. A 14-Year-Old Boy with Immune and Liver Abnormalities.
    N Engl J Med. 2015;373:2664-76.
    PubMed     Text format    


  68. MOHAN S
    Electrolyte and Acid-Base Disturbances in Diabetes Mellitus.
    N Engl J Med. 2015;373:2481-2483.
    PubMed     Text format     Abstract available


  69. BROUWERS MC
    Electrolyte and Acid-Base Disturbances in Diabetes Mellitus.
    N Engl J Med. 2015;373:2481-2483.
    PubMed     Text format     Abstract available


  70. RIGHI AM, Peeters MJ, Dotson B
    Electrolyte and Acid-Base Disturbances in Diabetes Mellitus.
    N Engl J Med. 2015;373:2481-2483.
    PubMed     Text format     Abstract available


  71. GRABER ML
    Electrolyte and Acid-Base Disturbances in Diabetes Mellitus.
    N Engl J Med. 2015;373:2481-2483.
    PubMed     Text format     Abstract available



  72. Electrolyte and Acid-Base Disturbances in Diabetes Mellitus.
    N Engl J Med. 2015;373:2481-2483.
    PubMed     Text format     Abstract available


  73. KAY GN
    Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available


  74. KUMAR HK
    Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available


  75. RUTTER MK, Wright AK, Ashcroft DM
    Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available



  76. Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
    N Engl J Med. 2015;373:2478-2479.
    PubMed     Text format     Abstract available


  77. PFEFFER MA, Claggett B, Diaz R, Dickstein K, et al
    Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
    N Engl J Med. 2015;373:2247-57.
    PubMed     Text format     Abstract available


    November 2015
  78. INGELFINGER JR, Rosen CJ
    Cardiovascular Risk and Sodium-Glucose Cotransporter 2 Inhibition in Type 2 Diabetes.
    N Engl J Med. 2015;373:2178-9.
    PubMed     Text format     Abstract available


  79. BOSELLO S, De Luca G, Ferraccioli G
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1977-8.
    PubMed     Text format    


  80. FARDMAN A
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1977.
    PubMed     Text format    


  81. KAVSAK PA
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1976-7.
    PubMed     Text format    


  82. LIPPI G, Targher G, Cervellin G
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1976.
    PubMed     Text format    


  83. EVERETT BM, Brooks MM, Bhatt DL
    Troponin in Stable Ischemic Heart Disease and Diabetes.
    N Engl J Med. 2015;373:1978-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: